AnalystsCatherine NovackCatherine Novack's Stock Forecasts
AnalystsCatherine Novack
Analyst Ranking
Top 35%
#1766 out of 5067 analysts
Average Return
+2.74%
Win Rate
32%7 out of 22
Risk vs Reward
Poor
Good
Catherine Novack's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Regulus Therapeutics IncRGLS | +248.47% | $2.29 | $7.98 | 2024-05-31 - 2025-04-30 | Strong Buy |
Palvella Therapeutics IncPVLA | +168.21% | $27.27 | $73.14 | 2025-03-25 - 2025-10-16 | Strong Buy |
Kezar Life Sciences IncKZR | +93.51% | $53.90 | $104.30 | 2021-07-20 - 2022-07-20 | Strong Buy |
Dyne Therapeutics IncDYN | +63.38% | $10.05 | $16.42 | 2025-06-26 - 2025-10-16 | Strong Buy |
Wave Life Sciences LtdWVE | +49.54% | $5.41 | $8.09 | 2024-08-09 - 2025-08-08 | Strong Buy |
Catherine Novack Analyst Color
Get additional color on Catherine Novack's coverage of popular stocks
Catherine Novack's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Aardvark Therapeutics IncAARD | 1 | Strong Buy | $33.00 | +148.12% | Initiates Coverage On | 16 days ago |
Dyne Therapeutics IncDYN | 1 | Strong Buy | $30.00 | +82.70% | Initiates Coverage On | 4 months ago |
Capricor Therapeutics IncCAPR | 2 | Strong Buy | $29.00 | +370.78% | Maintains | 4 months ago |
Femasys IncFEMY | 2 | Strong Buy | $6.00 | +705.37% | Maintains | 5 months ago |
Regulus Therapeutics IncRGLS | 2 | Hold | $7.00 | -14.22% | Downgrades | 6 months ago |
Palvella Therapeutics IncPVLA | 1 | Strong Buy | $45.00 | -38.47% | Initiates Coverage On | 7 months ago |
Proqr Therapeutics NvPRQR | 1 | Strong Buy | $11.00 | +292.86% | Initiates Coverage On | 8 months ago |
Korro Bio IncKRRO | 1 | Strong Buy | $130.00 | +167.49% | Initiates Coverage On | a year ago |
Wave Life Sciences LtdWVE | 2 | Strong Buy | $16.00 | N/A | Maintains | a year ago |
Larimar Therapeutics IncLRMR | 1 | Strong Buy | $14.00 | N/A | Initiates Coverage On | a year ago |
Dare Bioscience IncDARE | 2 | Strong Buy | $13.00 | N/A | Maintains | a year ago |
Rezolute IncRZLT | 1 | Strong Buy | $10.00 | N/A | Initiates Coverage On | a year ago |
Calcimedica IncCALC | 1 | Strong Buy | $22.00 | N/A | Initiates Coverage On | 2 years ago |
Purple Biotech LtdPPBT | 1 | Strong Buy | $160.00 | N/A | Initiates Coverage On | 2 years ago |
Omega Therapeutics IncOMGAQ | 1 | Strong Buy | $11.00 | N/A | Initiates Coverage On | 3 years ago |
Decibel Therapeutics IncDBTX | 1 | Strong Buy | $25.00 | N/A | Initiates Coverage On | 4 years ago |
Amryt Pharma PLCAMYT | 1 | Strong Buy | $45.00 | N/A | Initiates Coverage On | 4 years ago |
Kezar Life Sciences IncKZR | 1 | Strong Buy | $140.00 | N/A | Initiates Coverage On | 4 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.